Off-label prescribing of semaglutide drugs for weight loss has attracted a lot of controversy, especially as the drug remains in short supply as a type-2 diabetes treatment.

But the ire directed at larger individuals, both for using the drug and refusing not to, is rooted in fatphobia. We explore the state of Ozempic in Australia and what it's really like to use it for weight loss.

Plus, learn why the next generation of fiancées are turning away from the classic diamond engagement ring, and artist David Bromley opens up about his anxiety and the ways his art helps him stay on track.